-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/pharma-nonpharma-ptsd-2023-update-app-g-1.xlsx
January 01, 2023 - : Question 1.2 Bias Due to Randomization: Question 1.3 Bias Due to Randomization: Section 1 RoB Judgment … Interventions: Question 2.2 Bias Due to Deviations From Intended Interventions: Question 2.3 Bias Due … : Question 2.5 Bias Due to Deviations From Intended Interventions: Question 2.6 Bias Due to Deviations … 3.1 Detail Bias Due to Missing Outcome Data: Question 3.2 Bias Due to Missing Outcome Data: Question … RoB 2 questions
Question Number Question Text
1.1 Was the allocation sequence random?
-
effectivehealthcare.ahrq.gov/sites/default/files/delilberative-methods-design-gupta-2.pdf
May 29, 2025 - and establish
priorities for action
Slide 24
Six Facilitator Choices
As a “reaction” question … As a new starting question
Let there be silence
Move on
Paraphrase
Ask a “probing” or … “follow-up” question
Slide 25
Planning Considerations
Who will you ask to facilitate deliberation
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/ocr-protocol-final_1.pdf
December 18, 2019 - Question 3:
Outpatient comparison
of methods
Inclusion
Key Question 4: Fetal
Surveillance Exclusion … Question 3:
Outpatient comparison
of methods
Inclusion
Key Question 4: Fetal
Surveillance Exclusion … Question 3:
Outpatient comparison
of methods
Inclusion
Key Question 4: Fetal
Surveillance Exclusion … Question 3:
Outpatient comparison
of methods
Inclusion
Key Question 4: Fetal
Surveillance Exclusion … Question 3:
Outpatient comparison
of methods
Inclusion
Key Question 4: Fetal
Surveillance Exclusion
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/organization-cancer-care-disposition-comments.pdf
June 20, 2023 - We added a table 4
of Guiding Question 2
approaches. … We have added
callouts to identify
which question is
under discussion. … We
removed reference to
Guiding Question 3 in
the introduction to
Guiding Question 2. … We added a figure for
Guiding Question 2
themes that is similar
to Figure 6 (for
Guiding Question … Just raising the question.
-
effectivehealthcare.ahrq.gov/sites/default/files/cf_deliberativemethodswebinar_facilitation.pdf
May 29, 2025 - common
ground and establish priorities for action
2
Six Facilitator Choices
Ask a “reaction” question … Ask a new starting question
Let there be silence
Move on
Paraphrase
Ask a “probing” or “follow-up … ”
question
3
Planning Considerations
• Who will you ask to facilitate deliberation?
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-243-prehospital-airway-management-evidence-summary_0.pdf
June 01, 2021 - three
airway management approaches by emergency medical services in the prehospital
setting: Key Question … 1 – bag valve mask [BVM] versus supraglottic airway
[SGA]; Key Question 2 – BVM versus endotracheal … intubation [ETI]); Key
Question 3 – SGA versus ETI; and Key Question 4 – how the benefits and harms … 1, 22 studies), BVM to ETI
(Key Question 2, 22 studies), SGA to ETI (Key Question 3, 41 studies), or … compared
variations of one of the three airway approaches (Key Question 4, 51 studies).
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-future-research-steps-framework_research.pdf
June 01, 2011 - Key Question Number and Key Question Topic
• Research Gap Number
• Reason for Gap
• Population (P … The JHU EPC was assigned question 1, which is the following
question:
Define frameworks for determining … We
suggest use of the same format as above, but Key Question Number and Key Question Topic
would be … Question:
When Was
This Process
Initiated? … Number and Key Question Topic
Research Question
Limitations and Future Research
Conclusions
Background
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-238-cervical-ripening-evidence-summary.pdf
March 01, 2021 - Primary birth outcome: cesarean delivery
Key
Question Intervention Findingsa Studies Incidence
Relative … Risk
(95% CI)
I2 for Pooled
Analysesb
Key
Question 1:
Prostaglandin
Outpatient
vs. … Primary fetal harms outcomes
Key
Question Intervention Outcome Findingsa Studies Incidence
Relative … Risk
(95% CI)
I2 for Pooled
Analysesb
Key
Question 1:
Prostaglandin
Outpatient
vs. … Risk
(95% CI)
I2 for pooled
analysesb
Key
Question 2:
Mechanical
Method
Outpatient
vs.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/prioritized-research-agenda.pdf
October 01, 2021 - to address the
question. … Patient-centered
outcomes research
(short-term)
9
Broad Question Specific Questions Question … Treatment effectiveness
Broad Question Specific Questions Question Type
What is the comparative … Methods
development
11
Broad Question Specific Questions Question Type
How should treatment … Patient-centered
outcomes research
(short-term)
12
Broad Question Specific Questions Question
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-265-radiation-bone-disease-summary.pdf
August 01, 2023 - For Key
Question 2 (re-irradiation), two RCTs and three NRSIs met inclusion criteria; for Key
Question … EBRT alone), nine RCTs and seven NRSIs; and for
Key Question 3c (EBRT plus another modality vs. the … Key Question 1 compared EBRT dose-fraction schemes and delivery of initial
palliative radiation for … Evidence for Key Question 2 on dose-fraction schemes and delivery for re-irradiation
was sparse. … Comparative evidence for Key Question 3 on EBRT in conjunction with additional
therapies was sparse.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/musculoskeletal-complaints-tests-children_surveillance.pdf
January 08, 2013 - Key Question 3.2. … Key Question 3.5. … Do Not Know
Key Question 1. Prevalence and Incidence
Key Question 1.1. … Key Question 3.2. … Key Question 3.5.
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-228-nonopioid-pharm-chronic-pain-comments.pdf
April 16, 2020 - Public Reviewer 6
Anna Bono
Question 1 Personal anecdote including potentially private information … Public Reviewer 1
Karl Lorenz
Question 2 I find it quite problematic:
That you omit studies of “end … Public Reviewer 4
Jacob Marzalik,
American
Psychological
Association
Question 2 We appreciate the … Public Reviewer 6
Anna Bono
Question 4 Several studies in controlled settings have concluded that … Public Reviewer 7
Anonymous
Question 9 Thank you for this important contribution.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-262-pharmacotherapy-alcohol-summary.pdf
November 01, 2023 - Eligibility criteria for studies for each Key Question are described in the full report. … Key Question 1 included 111 studies, Key Question 2 included 31 studies, Key
Question 3 included 99 … studies, Key Question 4 included 1 study, and Key Question 5
included 9 studies. … Key Question 2: Health Outcomes. … We also eliminated a Key Question on pharmacogenomics that was in the
original review.
-
effectivehealthcare.ahrq.gov/sites/default/files/module_iii2.ppt
May 29, 2025 - *
Module III Quiz:
Question 1
1) Which of the following activities are opportunities for stakeholder … criteria
Discussing key questions
Illustrating clinical context for a topic
Module III Quiz:
Question … Protocol Development
Peer/Public Review
Report Translation & Dissemination
Module III Quiz:
Question … Protocol Development
Peer/Public Review
Report Translation & Dissemination
Module III Quiz:
Question … Module III Quiz:
Question 5: ANSWER
List three ways in which you could locate and recruit stakeholders
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/quality-gap-palliative-hospice_executive.pdf
October 01, 2012 - of Key Question 2. … Note: KQ = Key Question. … Key Question 2b: Evidence About Integrative and
Consultative Models
This Key Question was not analyzed … Key Question 2b: Evidence About Integrative and
Consultative Models
This Key Question was not analyzed … Key Question 2a: Evidence About Types of Quality
Improvement
This Key Question was not analyzed for
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/public-reporting-quality-improvement_executive.pdf
July 01, 2012 - Key Question 2
What harms result from public reporting? … • Outcomes (specified for each Key Question)
– Key Question 1. … – Key Question 2. … – Key Question 3. … – Key Question 4.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/case-management_executive.pdf
January 01, 2013 - Key Question 1a. … Key Question 1b. … Key Question 1c. … Key Question 3. … Low
Key Question 1a HIV Mortality.
-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/epc-maternal-health-grand-rounds-slides.pptx
January 01, 2023 - Agency for Healthcare Research and Quality (Rockville, Maryland, USA). 2023.
22
Key Question 1
What … 23
Key Question 1 – Population and Intervention Targets
Population
Postpartum (≤1 year after giving … group
Nonrandomized comparative studies (NRCSs) N≥30 per group
(prospective or retrospective)
Key Question … 1 – U.S. or Canada only
Key Question 2 – U.S. only
28
Evidence Identified
(92 studies)
Key Question … Key Question 3
What are the comparative effectiveness and harms of alternative magnesium sulfate (MgSO4
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/saturated-fat-replacement-protocol.pdf
January 01, 2024 - Key Questions
This systematic review will examine the Key Question as outlined below, based on the … Key Question 1: What are the effects of replacing dietary intake of total or
individual saturated fatty … Key Question 2: What are the effects of replacing dietary intake of total or
individual saturated fatty … 1 only)
o Children and adolescents (for Key
Question 1 only)
o Adults (19-64)
o Older adults (≥ … Review of Key Question
The Joint Canada-U.S.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/atypical-antipsychotics-off-label-update_research-protocol.pdf
May 19, 2010 - Population: Same as in Question 1
Intervention: Same as in Question 1
Comparator: Same as in Question … Timing: Same as in Question 1
Settings: Same as in Question 1
Question 3: What subset of the population … Timing: Same as in Question 1
Settings: Same as in Question 1
Question 4: What are the potential … Population: Same as in Question 1
Intervention: Same as in Question 1
Comparator: Same as in Question … Population: Same as in Question 1
Intervention: Same as in Question 1
Comparator: Same as in Question